nodes	percent_of_prediction	percent_of_DWPC	metapath
Tacrolimus—ABCB1—schizophrenia	0.442	1	CbGaD
Tacrolimus—PPP3CA—pons—schizophrenia	0.0258	0.112	CbGeAlD
Tacrolimus—PPP3CA—telencephalic ventricle—schizophrenia	0.0212	0.0924	CbGeAlD
Tacrolimus—PPP3CA—blood plasma—schizophrenia	0.0101	0.0441	CbGeAlD
Tacrolimus—ABCA5—telencephalon—schizophrenia	0.00754	0.0329	CbGeAlD
Tacrolimus—MTOR—blood plasma—schizophrenia	0.00747	0.0325	CbGeAlD
Tacrolimus—FKBP1A—blood plasma—schizophrenia	0.00672	0.0293	CbGeAlD
Tacrolimus—ABCA5—gonad—schizophrenia	0.00629	0.0274	CbGeAlD
Tacrolimus—PPP3CA—forebrain—schizophrenia	0.00554	0.0241	CbGeAlD
Tacrolimus—ABCA5—blood—schizophrenia	0.00548	0.0239	CbGeAlD
Tacrolimus—ABCA5—midbrain—schizophrenia	0.00541	0.0236	CbGeAlD
Tacrolimus—PPP3CA—telencephalon—schizophrenia	0.00509	0.0222	CbGeAlD
Tacrolimus—ABCA5—endocrine gland—schizophrenia	0.00475	0.0207	CbGeAlD
Tacrolimus—ABCA5—nervous system—schizophrenia	0.00445	0.0194	CbGeAlD
Tacrolimus—ABCA5—central nervous system—schizophrenia	0.00428	0.0187	CbGeAlD
Tacrolimus—CYP3A4—urine—schizophrenia	0.0042	0.0183	CbGeAlD
Tacrolimus—ABCA5—cerebellum—schizophrenia	0.00419	0.0183	CbGeAlD
Tacrolimus—MTOR—forebrain—schizophrenia	0.00409	0.0178	CbGeAlD
Tacrolimus—MTOR—telencephalon—schizophrenia	0.00376	0.0164	CbGeAlD
Tacrolimus—PPP3CA—blood—schizophrenia	0.0037	0.0161	CbGeAlD
Tacrolimus—FKBP1A—forebrain—schizophrenia	0.00368	0.016	CbGeAlD
Tacrolimus—PPP3CA—midbrain—schizophrenia	0.00366	0.0159	CbGeAlD
Tacrolimus—ABCA5—brain—schizophrenia	0.0034	0.0148	CbGeAlD
Tacrolimus—FKBP1A—telencephalon—schizophrenia	0.00338	0.0147	CbGeAlD
Tacrolimus—PPP3CA—endocrine gland—schizophrenia	0.00321	0.014	CbGeAlD
Tacrolimus—MTOR—gonad—schizophrenia	0.00314	0.0137	CbGeAlD
Tacrolimus—PPP3CA—nervous system—schizophrenia	0.00301	0.0131	CbGeAlD
Tacrolimus—CYP3A5—blood plasma—schizophrenia	0.00292	0.0127	CbGeAlD
Tacrolimus—PPP3CA—central nervous system—schizophrenia	0.00289	0.0126	CbGeAlD
Tacrolimus—PPP3CA—cerebellum—schizophrenia	0.00283	0.0123	CbGeAlD
Tacrolimus—FKBP1A—gonad—schizophrenia	0.00282	0.0123	CbGeAlD
Tacrolimus—MTOR—blood—schizophrenia	0.00274	0.0119	CbGeAlD
Tacrolimus—CYP3A7—endocrine gland—schizophrenia	0.00264	0.0115	CbGeAlD
Tacrolimus—FKBP1A—blood—schizophrenia	0.00246	0.0107	CbGeAlD
Tacrolimus—FKBP1A—midbrain—schizophrenia	0.00243	0.0106	CbGeAlD
Tacrolimus—MTOR—endocrine gland—schizophrenia	0.00237	0.0103	CbGeAlD
Tacrolimus—PPP3CA—brain—schizophrenia	0.0023	0.01	CbGeAlD
Tacrolimus—MTOR—nervous system—schizophrenia	0.00222	0.00968	CbGeAlD
Tacrolimus—CYP3A4—blood plasma—schizophrenia	0.00219	0.00957	CbGeAlD
Tacrolimus—MTOR—central nervous system—schizophrenia	0.00214	0.00932	CbGeAlD
Tacrolimus—FKBP1A—endocrine gland—schizophrenia	0.00213	0.0093	CbGeAlD
Tacrolimus—MTOR—cerebellum—schizophrenia	0.00209	0.00911	CbGeAlD
Tacrolimus—FKBP1A—nervous system—schizophrenia	0.002	0.00871	CbGeAlD
Tacrolimus—ORM1—blood—schizophrenia	0.00193	0.0084	CbGeAlD
Tacrolimus—FKBP1A—central nervous system—schizophrenia	0.00192	0.00838	CbGeAlD
Tacrolimus—FKBP1A—cerebellum—schizophrenia	0.00188	0.00819	CbGeAlD
Tacrolimus—MTOR—brain—schizophrenia	0.0017	0.0074	CbGeAlD
Tacrolimus—ORM1—endocrine gland—schizophrenia	0.00167	0.00728	CbGeAlD
Tacrolimus—Temsirolimus—CYP2D6—schizophrenia	0.00162	0.427	CrCbGaD
Tacrolimus—ORM1—nervous system—schizophrenia	0.00156	0.00682	CbGeAlD
Tacrolimus—ABCB1—blood plasma—schizophrenia	0.00155	0.00677	CbGeAlD
Tacrolimus—FKBP1A—brain—schizophrenia	0.00153	0.00665	CbGeAlD
Tacrolimus—ORM1—central nervous system—schizophrenia	0.00151	0.00656	CbGeAlD
Tacrolimus—Temsirolimus—ABCB1—schizophrenia	0.00116	0.305	CrCbGaD
Tacrolimus—CYP3A5—blood—schizophrenia	0.00107	0.00467	CbGeAlD
Tacrolimus—ALB—brain—schizophrenia	0.00105	0.00457	CbGeAlD
Tacrolimus—Sirolimus—ABCB1—schizophrenia	0.00102	0.268	CrCbGaD
Tacrolimus—CYP3A5—endocrine gland—schizophrenia	0.000929	0.00405	CbGeAlD
Tacrolimus—ABCB1—forebrain—schizophrenia	0.000851	0.00371	CbGeAlD
Tacrolimus—CYP3A4—blood—schizophrenia	0.000804	0.0035	CbGeAlD
Tacrolimus—ABCB1—telencephalon—schizophrenia	0.000782	0.00341	CbGeAlD
Tacrolimus—CYP3A4—endocrine gland—schizophrenia	0.000697	0.00304	CbGeAlD
Tacrolimus—ABCB1—gonad—schizophrenia	0.000653	0.00285	CbGeAlD
Tacrolimus—CYP3A4—nervous system—schizophrenia	0.000653	0.00285	CbGeAlD
Tacrolimus—CYP3A4—central nervous system—schizophrenia	0.000628	0.00274	CbGeAlD
Tacrolimus—ABCB1—blood—schizophrenia	0.000569	0.00248	CbGeAlD
Tacrolimus—ABCB1—midbrain—schizophrenia	0.000562	0.00245	CbGeAlD
Tacrolimus—ABCB1—endocrine gland—schizophrenia	0.000494	0.00215	CbGeAlD
Tacrolimus—ABCB1—nervous system—schizophrenia	0.000462	0.00201	CbGeAlD
Tacrolimus—ABCB1—central nervous system—schizophrenia	0.000445	0.00194	CbGeAlD
Tacrolimus—ABCB1—cerebellum—schizophrenia	0.000435	0.0019	CbGeAlD
Tacrolimus—ABCB1—brain—schizophrenia	0.000353	0.00154	CbGeAlD
Tacrolimus—MTOR—Signaling Pathways—PDE4B—schizophrenia	4.84e-05	0.000149	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—ESR1—schizophrenia	4.83e-05	0.000149	CbGpPWpGaD
Tacrolimus—MTOR—B Cell Activation—AKT1—schizophrenia	4.81e-05	0.000148	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—PLA2G4A—schizophrenia	4.77e-05	0.000147	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CCKAR—schizophrenia	4.76e-05	0.000146	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—ATP2A2—schizophrenia	4.74e-05	0.000146	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—GAPDH—schizophrenia	4.73e-05	0.000146	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—CLOCK—schizophrenia	4.69e-05	0.000144	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—NRG1—schizophrenia	4.68e-05	0.000144	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PNP—schizophrenia	4.67e-05	0.000144	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PIP4K2A—schizophrenia	4.66e-05	0.000143	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PRODH—schizophrenia	4.66e-05	0.000143	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—MEF2C—schizophrenia	4.64e-05	0.000143	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—AKT1—schizophrenia	4.63e-05	0.000142	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—ADORA2A—schizophrenia	4.62e-05	0.000142	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—CYP1A2—schizophrenia	4.62e-05	0.000142	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—S100B—schizophrenia	4.61e-05	0.000142	CbGpPWpGaD
Tacrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—AKT1—schizophrenia	4.6e-05	0.000142	CbGpPWpGaD
Tacrolimus—MTOR—Disease—PRL—schizophrenia	4.57e-05	0.000141	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—TPH2—schizophrenia	4.57e-05	0.000141	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—CACNB2—schizophrenia	4.57e-05	0.000141	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—DPYD—schizophrenia	4.5e-05	0.000138	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—YWHAZ—schizophrenia	4.48e-05	0.000138	CbGpPWpGaD
Tacrolimus—MTOR—Cellular responses to stress—TP53—schizophrenia	4.47e-05	0.000137	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—EP300—schizophrenia	4.46e-05	0.000137	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—FGA—schizophrenia	4.43e-05	0.000136	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—ERBB4—schizophrenia	4.41e-05	0.000136	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—ERBB3—schizophrenia	4.39e-05	0.000135	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—GSK3B—schizophrenia	4.38e-05	0.000135	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—TPH1—schizophrenia	4.36e-05	0.000134	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—GCLM—schizophrenia	4.36e-05	0.000134	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—NDUFV2—schizophrenia	4.34e-05	0.000133	CbGpPWpGaD
Tacrolimus—ALB—Transmembrane transport of small molecules—SLC6A3—schizophrenia	4.33e-05	0.000133	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—NPY—schizophrenia	4.31e-05	0.000133	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—NOTCH4—schizophrenia	4.31e-05	0.000133	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—ATP2A2—schizophrenia	4.31e-05	0.000133	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—HTR2A—schizophrenia	4.22e-05	0.00013	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—CYP26B1—schizophrenia	4.21e-05	0.00013	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—CACNA1C—schizophrenia	4.18e-05	0.000129	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—HTR1B—schizophrenia	4.16e-05	0.000128	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—OXT—schizophrenia	4.16e-05	0.000128	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—EP300—schizophrenia	4.12e-05	0.000127	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—PRKD1—schizophrenia	4.1e-05	0.000126	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PIP4K2A—schizophrenia	4.08e-05	0.000126	CbGpPWpGaD
Tacrolimus—MTOR—Disease—ERBB4—schizophrenia	4.07e-05	0.000125	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—PIK3C2A—schizophrenia	4.07e-05	0.000125	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—NRG1—schizophrenia	4.07e-05	0.000125	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—MEF2C—schizophrenia	4.04e-05	0.000124	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—HTR1A—schizophrenia	4.01e-05	0.000123	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—NPS—schizophrenia	3.95e-05	0.000121	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—APOE—schizophrenia	3.92e-05	0.000121	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—YWHAZ—schizophrenia	3.9e-05	0.00012	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—PLA2G4A—schizophrenia	3.89e-05	0.00012	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—APOA1—schizophrenia	3.88e-05	0.000119	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—HTR2C—schizophrenia	3.87e-05	0.000119	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—DRD1—schizophrenia	3.87e-05	0.000119	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—ERBB3—schizophrenia	3.82e-05	0.000117	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—MPC2—schizophrenia	3.79e-05	0.000117	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—SLC6A3—schizophrenia	3.79e-05	0.000117	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—NTRK2—schizophrenia	3.76e-05	0.000116	CbGpPWpGaD
Tacrolimus—MTOR—Disease—NRG1—schizophrenia	3.76e-05	0.000116	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—TPH1—schizophrenia	3.75e-05	0.000115	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—GCLM—schizophrenia	3.75e-05	0.000115	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—DRD3—schizophrenia	3.75e-05	0.000115	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—ESR1—schizophrenia	3.75e-05	0.000115	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CYP26B1—schizophrenia	3.69e-05	0.000113	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—YWHAZ—schizophrenia	3.66e-05	0.000112	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—CYP2D6—schizophrenia	3.65e-05	0.000112	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—SNAP25—schizophrenia	3.65e-05	0.000112	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—DRD4—schizophrenia	3.64e-05	0.000112	CbGpPWpGaD
Tacrolimus—MTOR—Disease—YWHAZ—schizophrenia	3.6e-05	0.000111	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—PLA2G4A—schizophrenia	3.54e-05	0.000109	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by NGF—AKT1—schizophrenia	3.54e-05	0.000109	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PRKD1—schizophrenia	3.53e-05	0.000109	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PLCH2—schizophrenia	3.53e-05	0.000109	CbGpPWpGaD
Tacrolimus—MTOR—Disease—ERBB3—schizophrenia	3.52e-05	0.000108	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—schizophrenia	3.48e-05	0.000107	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CNR1—schizophrenia	3.47e-05	0.000107	CbGpPWpGaD
Tacrolimus—ALB—Transmembrane transport of small molecules—ABCB1—schizophrenia	3.47e-05	0.000107	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—GAPDH—schizophrenia	3.42e-05	0.000105	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—GSK3B—schizophrenia	3.4e-05	0.000105	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—DRD2—schizophrenia	3.39e-05	0.000104	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—HTR7—schizophrenia	3.39e-05	0.000104	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—CLOCK—schizophrenia	3.39e-05	0.000104	CbGpPWpGaD
Tacrolimus—MTOR—Disease—MTHFR—schizophrenia	3.39e-05	0.000104	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—EP300—schizophrenia	3.34e-05	0.000103	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—NDST3—schizophrenia	3.32e-05	0.000102	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—CYP1A2—schizophrenia	3.3e-05	0.000102	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—TPH2—schizophrenia	3.3e-05	0.000102	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—CACNB2—schizophrenia	3.3e-05	0.000102	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—GCLM—schizophrenia	3.29e-05	0.000101	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—TPH1—schizophrenia	3.29e-05	0.000101	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—TH—schizophrenia	3.26e-05	0.0001	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—DPYD—schizophrenia	3.25e-05	0.0001	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—PRL—schizophrenia	3.2e-05	9.85e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—EP300—schizophrenia	3.19e-05	9.82e-05	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—APOA1—schizophrenia	3.16e-05	9.73e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—APOE—schizophrenia	3.15e-05	9.69e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—SLC27A5—schizophrenia	3.14e-05	9.67e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ACSL6—schizophrenia	3.14e-05	9.67e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—APOA1—schizophrenia	3.12e-05	9.58e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PRKD1—schizophrenia	3.09e-05	9.51e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—CACNA1C—schizophrenia	3.02e-05	9.29e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—DAO—schizophrenia	3e-05	9.23e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—S100B—schizophrenia	2.98e-05	9.18e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—GSK3B—schizophrenia	2.96e-05	9.09e-05	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—AKT1—schizophrenia	2.95e-05	9.08e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—GAPDH—schizophrenia	2.95e-05	9.06e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—PIK3C2A—schizophrenia	2.94e-05	9.06e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—FOS—schizophrenia	2.94e-05	9.03e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—CLOCK—schizophrenia	2.92e-05	8.98e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—APOE—schizophrenia	2.91e-05	8.96e-05	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—EP300—schizophrenia	2.88e-05	8.87e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	2.88e-05	8.85e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PNP—schizophrenia	2.88e-05	8.85e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—ERBB4—schizophrenia	2.85e-05	8.78e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—TPH2—schizophrenia	2.84e-05	8.75e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—CACNB2—schizophrenia	2.84e-05	8.75e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—schizophrenia	2.83e-05	8.69e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—DPYD—schizophrenia	2.8e-05	8.61e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—COMT—schizophrenia	2.77e-05	8.52e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—GSTP1—schizophrenia	2.76e-05	8.48e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—MAOA—schizophrenia	2.75e-05	8.46e-05	CbGpPWpGaD
Tacrolimus—ALB—Transmembrane transport of small molecules—APOA1—schizophrenia	2.74e-05	8.42e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—GSK3B—schizophrenia	2.73e-05	8.4e-05	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—AKT1—schizophrenia	2.7e-05	8.29e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—PLA2G4A—schizophrenia	2.68e-05	8.25e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—NDUFV2—schizophrenia	2.67e-05	8.22e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—CYP2D6—schizophrenia	2.64e-05	8.12e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—SNAP25—schizophrenia	2.64e-05	8.12e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—NRG1—schizophrenia	2.63e-05	8.1e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—MEF2C—schizophrenia	2.61e-05	8.03e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—ABCB1—schizophrenia	2.61e-05	8.02e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—CACNA1C—schizophrenia	2.6e-05	8e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—GAPDH—schizophrenia	2.58e-05	7.94e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CLOCK—schizophrenia	2.56e-05	7.87e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PIK3C2A—schizophrenia	2.54e-05	7.8e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—PLA2G4A—schizophrenia	2.53e-05	7.79e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—GSTM1—schizophrenia	2.53e-05	7.79e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—YWHAZ—schizophrenia	2.52e-05	7.76e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PIP4K2A—schizophrenia	2.51e-05	7.73e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—TPH2—schizophrenia	2.49e-05	7.67e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CACNB2—schizophrenia	2.49e-05	7.67e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—schizophrenia	2.49e-05	7.67e-05	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—AKT1—schizophrenia	2.49e-05	7.66e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—ERBB3—schizophrenia	2.47e-05	7.59e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—DPYD—schizophrenia	2.45e-05	7.54e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—APOA1—schizophrenia	2.4e-05	7.38e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—CYP1A2—schizophrenia	2.39e-05	7.35e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—HTR2A—schizophrenia	2.37e-05	7.3e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—TH—schizophrenia	2.35e-05	7.24e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CACNA1C—schizophrenia	2.28e-05	7.01e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—CYP2D6—schizophrenia	2.27e-05	7e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—SNAP25—schizophrenia	2.27e-05	7e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CYP26B1—schizophrenia	2.27e-05	6.99e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—MTHFR—schizophrenia	2.24e-05	6.88e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—EP300—schizophrenia	2.24e-05	6.88e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PIK3C2A—schizophrenia	2.22e-05	6.83e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—APOE—schizophrenia	2.21e-05	6.79e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—APOA1—schizophrenia	2.18e-05	6.71e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IL1B—schizophrenia	2.18e-05	6.69e-05	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—AKT1—schizophrenia	2.14e-05	6.57e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—ESR1—schizophrenia	2.11e-05	6.48e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—schizophrenia	2.1e-05	6.47e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—APOE—schizophrenia	2.08e-05	6.41e-05	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—TP53—schizophrenia	2.06e-05	6.35e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—APOA1—schizophrenia	2.06e-05	6.33e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—CYP1A2—schizophrenia	2.06e-05	6.33e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—TH—schizophrenia	2.03e-05	6.23e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—TPH1—schizophrenia	2.03e-05	6.23e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GCLM—schizophrenia	2.03e-05	6.23e-05	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—AKT1—schizophrenia	2.02e-05	6.21e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—COMT—schizophrenia	2e-05	6.16e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CYP2D6—schizophrenia	1.99e-05	6.13e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—SNAP25—schizophrenia	1.99e-05	6.13e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—GSTP1—schizophrenia	1.99e-05	6.13e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—MAOA—schizophrenia	1.99e-05	6.11e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—EP300—schizophrenia	1.95e-05	5.98e-05	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—AKT1—schizophrenia	1.94e-05	5.96e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—AKT1—schizophrenia	1.93e-05	5.94e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—GSK3B—schizophrenia	1.91e-05	5.88e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PRKD1—schizophrenia	1.91e-05	5.86e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—ABCB1—schizophrenia	1.89e-05	5.8e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—PLA2G4A—schizophrenia	1.83e-05	5.63e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—GSTM1—schizophrenia	1.83e-05	5.63e-05	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—EP300—schizophrenia	1.82e-05	5.61e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CYP1A2—schizophrenia	1.8e-05	5.54e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—EP300—schizophrenia	1.8e-05	5.52e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—TH—schizophrenia	1.78e-05	5.46e-05	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—AKT1—schizophrenia	1.74e-05	5.36e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—COMT—schizophrenia	1.72e-05	5.3e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—GSTP1—schizophrenia	1.72e-05	5.28e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—MAOA—schizophrenia	1.71e-05	5.26e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—EP300—schizophrenia	1.66e-05	5.1e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—ABCB1—schizophrenia	1.62e-05	4.99e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—MTHFR—schizophrenia	1.62e-05	4.98e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—TP53—schizophrenia	1.6e-05	4.92e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GAPDH—schizophrenia	1.59e-05	4.89e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PLA2G4A—schizophrenia	1.58e-05	4.85e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—GSTM1—schizophrenia	1.58e-05	4.85e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CLOCK—schizophrenia	1.58e-05	4.85e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—TPH2—schizophrenia	1.54e-05	4.72e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CACNB2—schizophrenia	1.54e-05	4.72e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—DPYD—schizophrenia	1.51e-05	4.65e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—COMT—schizophrenia	1.51e-05	4.64e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—APOE—schizophrenia	1.51e-05	4.63e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—GSTP1—schizophrenia	1.5e-05	4.62e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—MAOA—schizophrenia	1.5e-05	4.61e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—APOA1—schizophrenia	1.49e-05	4.58e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CACNA1C—schizophrenia	1.4e-05	4.32e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—MTHFR—schizophrenia	1.39e-05	4.29e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PLA2G4A—schizophrenia	1.38e-05	4.25e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—GSTM1—schizophrenia	1.38e-05	4.25e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PIK3C2A—schizophrenia	1.37e-05	4.21e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—AKT1—schizophrenia	1.35e-05	4.16e-05	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—TP53—schizophrenia	1.3e-05	4.01e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—APOE—schizophrenia	1.3e-05	3.99e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—APOA1—schizophrenia	1.28e-05	3.94e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—EP300—schizophrenia	1.26e-05	3.87e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CYP2D6—schizophrenia	1.23e-05	3.78e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—SNAP25—schizophrenia	1.23e-05	3.78e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—MTHFR—schizophrenia	1.22e-05	3.75e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—EP300—schizophrenia	1.19e-05	3.65e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—AKT1—schizophrenia	1.18e-05	3.62e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—APOE—schizophrenia	1.14e-05	3.5e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—APOA1—schizophrenia	1.12e-05	3.46e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CYP1A2—schizophrenia	1.11e-05	3.41e-05	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—AKT1—schizophrenia	1.1e-05	3.39e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—TH—schizophrenia	1.09e-05	3.37e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—AKT1—schizophrenia	1.09e-05	3.34e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—COMT—schizophrenia	9.3e-06	2.86e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GSTP1—schizophrenia	9.26e-06	2.85e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—MAOA—schizophrenia	9.24e-06	2.84e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—TP53—schizophrenia	9e-06	2.77e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ABCB1—schizophrenia	8.77e-06	2.7e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—EP300—schizophrenia	8.58e-06	2.64e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GSTM1—schizophrenia	8.51e-06	2.62e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PLA2G4A—schizophrenia	8.51e-06	2.62e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—AKT1—schizophrenia	7.6e-06	2.34e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—MTHFR—schizophrenia	7.52e-06	2.31e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—EP300—schizophrenia	7.39e-06	2.27e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—AKT1—schizophrenia	7.17e-06	2.21e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—APOE—schizophrenia	7e-06	2.15e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—APOA1—schizophrenia	6.92e-06	2.13e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—EP300—schizophrenia	6.48e-06	1.99e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—AKT1—schizophrenia	5.19e-06	1.6e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—AKT1—schizophrenia	4.47e-06	1.37e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—EP300—schizophrenia	3.99e-06	1.23e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—AKT1—schizophrenia	3.91e-06	1.2e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—AKT1—schizophrenia	2.41e-06	7.42e-06	CbGpPWpGaD
